PTC Therapeutics Granted Marketing Authorization By EU For Upstaza To Treat AADC Deficiency

RTTNews | 1028 dni temu
PTC Therapeutics Granted Marketing Authorization By EU For Upstaza To Treat AADC Deficiency

(RTTNews) - PTC Therapeutics, Inc. (PTCT) announced Wednesday that Upstaza (eladocagene exuparvovec) was granted marketing authorization by the European Commission. Upstaza is the first approved disease-modifying treatment for aromatic L-amino acid decarboxylase (AADC) deficiency and the first marketed gene therapy directly infused into the brain. It is approved for patients 18 months and older.

Upstaza is a one-time gene replacement therapy indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of AADC deficiency with a severe phenotype.

The marketing authorization is applicable to all 27 European Union member states, as well as Iceland, Norway and Liechtenstein.

For More Such Health News, visit rttnews.com

read more
FDA Approves PTC's Kebilidi As First Gene Therapy To Treat AADC Deficiency

FDA Approves PTC's Kebilidi As First Gene Therapy To Treat AADC Deficiency

The U.S. Food and Drug Administration approved PTC Therapeutics, Inc.'s Kebilidi (eladocagene exuparvovec-tneq) gene therapy for the treatment of aromatic L-amino acid decarboxylase or AADC deficiency. Kebilidi is the first FDA-approved gene therapy for the deficiency. PTC shares gained around 8.5 percent in the extended trading on the Nasdaq on Thursday.
RTTNews | 180 dni temu
Mild Rebound Tipped For Hong Kong Shares

Mild Rebound Tipped For Hong Kong Shares

The Hong Kong stock market on Tuesday ended the eight-day winning streak in which it had surged almost 1,600 points or 7.1 percent. The Hang Seng Index now sits just beneath the 23,110-point plateau although it may tick back to the upside again on Wednesday.
RTTNews | 15 minut temu
Australian Market Slightly Lower

Australian Market Slightly Lower

Australian shares are trading slightly lower on Wednesday, snapping a five-session winning streak, with the benchmark S&P/ASX 200 staying well below the 8,300 level, following the mixed cues from Wall Street overnight, with a mixed performance across most sectors. Traders are also booking some profits following the recent upside in the markets.
RTTNews | 21 minut temu
China Bourse Tipped To Open In The Green

China Bourse Tipped To Open In The Green

The China stock market has moved higher in consecutive trading days, improving almost 35 points or 1 percent along the way. The Shanghai Composite Index now rests just beneath the 3,375-point plateau and it's looking at a higher open again on Wednesday.
RTTNews | 30 minut temu
Tech Shares May Boost Taiwan Stock Market

Tech Shares May Boost Taiwan Stock Market

The Taiwan stock market has moved higher in three straight sessions, collecting almost 800 points or 4 percent in that span. The Taiwan Stock Exchange now sits just above the 21,330-point plateau and it's likely to open to the upside again on Wednesday.
RTTNews | 1g 0 minut temu
Japan Producer Prices Rise 0.2% In April

Japan Producer Prices Rise 0.2% In April

Producer prices in Japan were up 0.2 percent on month in April, the Bank of Japan said on Wednesday - slowing from 0.4 percent in March.
RTTNews | 1g 4 minut temu
Singapore Bourse May Crack Resistance At 3,900 Points

Singapore Bourse May Crack Resistance At 3,900 Points

The Singapore stock market has tracked higher in back-to-back sessions, gathering more than 30 points or 0.8 percent along the way. The Straits Times Index now sits just above the 3,880-point plateau and it may see additional support on Wednesday.
RTTNews | 1g 30 minut temu